UTILISATION DE CYSTINE OU DE CYSTEINE DANS LA PREVENTION ET LE TRAITEMENT DU STRESS OXYDATIF CAUSE PAR L'HEMODIALYSE ET DES NEPHROPATHIES CHRONIQUES OU AIGUES
The invention discloses the use of cystine and/or cysteine for the preparationof oral medicinal products for the prevention and treatment of oxidativestress resulting from haemodialysis treatment in patients suffering fromchronic kidney failure as well as for the treatment and prevention of acute orchronic kidney diseases and of End-Stage Renal-Disease.
